Nonsurgical management of gallbladder cancer: Cytotoxic treatment and radiotherapy

Expert Review of Anticancer Therapy

Volumn 1, Issue 2, 2001, Pages 291-300

  Hejna, Michael ^a   Zielinski, Christoph C ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chemotherapy gallbladder cancer; Radiotherapy

Indexed keywords

CAPECITABINE; CARBOQUONE; CARMUSTINE; CISPLATIN; CYTOTOXIC AGENT; DOCETAXEL; DOXIFLURIDINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; HYDROXYUREA; LOMUSTINE; METHOTREXATE; MITOMYCIN C; PACLITAXEL; RECOMBINANT ALPHA2B INTERFERON; STREPTOZOCIN; TEGAFUR; THIOTEPA;

ALOPECIA; ANTINEOPLASTIC ACTIVITY; BLOOD TOXICITY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL STUDY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FIRST PASS EFFECT; GALLBLADDER CARCINOMA; GASTROINTESTINAL SYMPTOM; HAND FOOT SYNDROME; HUMAN; HYPOTENSION; INOPERABLE CANCER; METASTASIS; NAUSEA AND VOMITING; PEROPERATIVE CARE; REVIEW; SYMPTOMATOLOGY; TREATMENT FAILURE;

EID: 0035557936     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.1.2.291     Document Type: Review

References (68)

1. Malignancies of the biliary tree
2. Carcinoma of the gallbladder
3. Carcinoma and polyps of the gallbladder associated with Peutz-Jeghers syndrome
4. Pathology of carcinoma of the gallbladder
5. Primary carcinoma of the gallbladder
6. Surgical treatment of cholangiocellular carcinoma
7. Perspectives in chemotherapy of pancreatic cancer
8. The role of intraoperative radiation therapy in the treatment of bile duct cancer
9. Irradiation of biliary carcinoma
10. Intraluminal radiation therapy for biliary tract malignancy - An endoscopic approach
11. Endoscopic implantation of iridium wire for treatment of carcinoma of the biliary duct
12. Carcinoma of the gallbladder: A study of 390 cases diagnosed in Finland 1953-1967
13. Primary carcinoma of the gallbladder: Adjuvant postoperative external irradiation
14. Carcinoma of the extrahepatic biliary system - Results of primary and adjuvant radiotherapy
15. Gallbladder carcinoma: Role of radiation therapy
16. The role of radiation therapy in cancer of the extra-hepatic biliary system. An analysis of 13 patients and a review of the literature of the effectiveness of surgery, chemotherapy and radiotherapy
17. Radiation therapy of carcinoma of the gallbladder and biliary tract
18. Primary carcinoma of the gallbladder. The role of adjunctive therapy and its management
19. Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases
20. Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma
21. Resection combined with intraoperative radiation therapy (IORT) for stage IV (TNM) gallbladder carcinoma
22. Intraoperative radiation therapy for carcinoma of the gallbladder
23. Chemotherapy of Cancer Mitomycin C
24. The gallbladder
25. Phase II trial of mitomycin C in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cooperative Group Study
26. Adenocarcinomas of stomach, pancreas, liver and biliary tracts
27. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer
28. Chemotherapy for unresectable biliary cancer
29. A Phase II study of cisplatin in patients with biliary tract carcinoma
30. Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas
31. Phase II trial of gemcitabine in biliary tract cancers
32. Phase II trial of a weekly 150-minute gemcitabine infusion in patients with biliary tree carcinomas
33. Gemcitabine (GEM): An active drug in advanced gallbladder cancer (AGC)
34. Oral Capecitabine (Xeloda) for the treatment of hepatobiliary cancers (hepatocellular carcinoma, cholangiocarcinoma and gallbladder cancer)
35. Adriamycin, BCNU, frorafur chemotherapy of pancreatic and biliary tract cancer
36. Phase II trial of cisplatin, epirubicin and continuous infusion 5-fluorouracil (5-FU) (CEF therapy) for advanced gallbladder cancer (GBC)
37. Efficacy of 48-hour infusion of 5-fluorouracil for gallbladder cancer
38. A Phase II study of combined 5-fluorouracil, doxorubicin, cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas
39. Epirubicin-sequential methotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A Phase II study
40. Comparison of 5-fluorouracil, doxorubicin and mitomycin with 5-fluorouracil alone in treatment of pancreatic-biliary carcinoma
41. Carcinoma of the gallbladder. The Roswell Park experience
42. Regional chemotherapy of colorectal cancer
43. Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine
44. A new look at the arterial supply of the bile duct in man and its surgical implications
45. Superselective intraarterial chemotherapy with mitomycin for gallbladder cancer
46. Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma
47. Hepatic perfusion with FUdR utilizing an implantable system in patients with liver primary cancer or metastatic cancer confined to the liver
48. Study of hepatic arterial chemoinfusion with continous CDDP, 5-FU, low dose administration for advanced gallbladder cancer
49. Superselective intra-arterial chemotherapy with mitomycin C in liver and gallbladder cancer
50. The role of chemotherapy and radiation in the management of biliary cancer: A review of the literature
51. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
52. Primary carcinoma of the gallbladder: Adjuvant postoperative external irradiation
53. Primary carcinoma of the gallbladder: Potential for external radiation therapy
54. Toxicity of irinotecan (CPT-11) in patients with advanced gallbladder (GB) or biliary (BILI) tumors: A North Central Cancer Treatment Group (NCCTG) study
55. Phase II study of docetaxel with g-csf support as first-line treatment for unresectable or advanced biliary tract carcinoma: A multicenter Phase II trial
56. Intrahepatic arterial infusion of combination of mitomycin C and 5-fluorouracil in treatment of primary and metastatic liver carcinoma
57. Mitomycin C in advanced gallbladder carcinoma
58. Arterial infusion of combination chemotherapy using adriamycin and mitomycin C for hepatoma and metastatic tumor of the liver
59. A case of gallbladder cancer successfully treated with UFTM therapy
60. MQF-FT and MQF-UFT in gallbladder and bile duct cancer
61. A case of gallbladder cancer with marked response to EAP treatment
62. Clinical and pharmacological study of intrahepatic artery infusion of thiotepa
63. Two cases of improved quality of life with intra-arterial infusion of CDDP for unresectable gallbladder and pancreatic cancer
64. Oral chemotherapy with doxifluridine and folinic acid in biliary tract cancer
65. Pilot study of ambulatory infusional delivery of a multidrug regimen: Cisplatin, 5-fluorouracil and leucovorin (PFL) ± etoposide
66. Treatment of advanced adenocarcinomas of the exocrine pancreas and gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Result of a multicenter study of the Italy Oncology Group (G.O.I.M.)
67. A Phase II study of 5-fluorouracil, leucovorin and carboplatin in patients with unresectable biliary tree carcinoma
68. Phase II trial of intravenous fluorouracil and subcutaneous interferon α-2b for biliary tract cancer